Ethyl 4-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98%, 100mg

2-Chloro-5h,6h,7h-cyclopenta[d]pyrimidin-4-amine, 95%, 1g

2-CYCLOPROPYL-4-(TRIFLUOROMETHYL)BENZOIC ACID, 97.0%, 250mg

4-(4-(Pyrrolidin-1-yl)piperidin-1-yl)aniline, 98%, 1g

1,3,2-Dioxaborolane, 2-[3-[(4-chlorophenyl)methoxy]phenyl]-4,4,5,5-tetramethyl-, 95%, 5g

3-Bromo-2-chloro-4-methoxypyridine, 95.0%, 25g

4-Hydroxy-3-methylbenzaldehyde, 97.0%, 25g

2-Chloro-1-(pyridin-3-yl)ethanone hydrochloride, 95.0%, 100mg

3-(Aminomethyl)-4,6-dimethylpyridin-2(1H)-one, 95.0%, 250mg

(R)-2-Amino-3-sulfopropanoic acid hydrate, 95.0%, 25g

(R)-4-Hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 95.0%, 5g

Télescope pour contraste de phase tube Ø 30 mm

2-(4-Bromothiophen-2-yl)ethan-1-amine hydrochloride, 96%, 250mg